Thus, our study investigated whether B7‐H3, which is highly expressed by NPC tumor cells, interacts with 4‐1BB protein on the surface of CD8+ T cells to inhibit its protein activity and ultimately suppress the tumor antigen‐specific immune response. The gene discussed is TNFRSF9; the disease is neoplasm.